NCT01616758 2024-03-08Phase II Study of GTx024 in Women With Metastatic Breast CancerGTxPhase 2 Terminated22 enrolled 5 charts
NCT02368691 2020-11-18Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)GTxPhase 2 Terminated32 enrolled 12 charts